Latest News
Feature
HHS creates new religious freedoms division
The Trump administration has announced a new division within the U.S. Health & Human Services Department that aims to protect health care...
From the Journals
AAD guidelines favor surgery for nonmelanoma skin cancers
The guidelines for basal cell and cutaneous squamous cell carcinoma also discuss biopsy techniques, tumor staging, and prevention of recurrence of...
Conference Coverage
Novel JAK1 inhibitor shows promise for myeloid malignancies
ATLANTA – A novel JAK1 inhibitor shows encouraging activity, particularly with azacitidine, in certain patients with advanced myeloid malignancies...
Latest News
Immune-modified RECIST can help identify survival benefit from cancer immunotherapy
Analyses of early trials of atezolizumab for NSCLC and bladder cancer reveal aspects of immune-modified RECIST that seem to predict OS better than...
From the Journals
HIPEC shows survival benefit for advanced ovarian cancer
Hyperthermic intraperitoneal chemotherapy showed survival benefit without increasing risk for side effects in phase 3 study.
From the Journals
Thrombosis risk is elevated with myeloproliferative neoplasms
Diagnosis appears to be the time with greatest risk.
From the Journals
OS similar among mRCC patients enrolled in clinical trials across different geographic regions
Despite different baseline characteristics, OS was similar among patients enrolled in clinical trials across different geographic regions.
News
FDA grants priority review to CAR T-cell therapy for DLBCL
The application for tisagenlecleucel suspension is based on results from the phase 2 JULIET trial.
News
FDA approves injection treatment for low-risk APL
The expanded indication allows for first-line treatment for adults with newly diagnosed low-risk acute promyelocytic leukemia.
From the Journals
Desmoplastic melanoma yields to checkpoint inhibitors
Of 60 patients with desmoplastic melanoma treated with checkpoint inhibitors and followed for a median of 22 months, 42 had an objective response...
Feature
MedPAC recommends scrapping MIPS, gets pushback from doctors
While MIPS is not perfect, doctors are not likely to be pleased by having to shift midstream.